Dana-Farber Cancer Institute Software Engineering Manager Salary
The average Dana-Farber Cancer Institute Software Engineering Manager earns an estimated $170,229 annually, which includes an estimated base salary of $147,007 with a $23,222 bonus. Dana-Farber Cancer Institute's Software Engineering Manager compensation is $10,653 more than the US average for a Software Engineering Manager. Software Engineering Manager salaries at Dana-Farber Cancer Institute can range from $120,000 - $234,000.
The Engineering Department at Dana-Farber Cancer Institute earns $3,576 more on average than the HR Department.
Last updated 4 months ago.
- $147,007
- avg. base
- $23,222
- avg. bonus
Software Engineering Manager Salaries at Dana-Farber Cancer Institute
Software Engineering Managers earn $7,225 more than Engineering Managers, and $18,212 less than Group Engineering Managers.
Compensation at Dana-Farber Cancer Institute by Department
The Engineering Department averages $3,576 more than the HR Department, and $38,051 less than the Enterprise Risk Department
Software Engineering Manager Compensation by Gender (All Companies)
The average female Software Engineering Manager at companies similar size to Dana-Farber Cancer Institute reported making $178,636, while the average male Software Engineering Manager at similar sized companies reported making $175,656.
Software Engineering Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Software Engineering Manager at companies similar size to Dana-Farber Cancer Institute reported making $185,235, while the average Native American Software Engineering Manager at similar sized companies reported making $89,000.
How Software Engineering Managers at Dana-Farber Cancer Institute Rate Their Compensation
The majority of Software Engineering Managers at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Software Engineering Managers at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute
